Mimedx (MDXG) Capital Expenditures (2011 - 2026)
Mimedx recorded quarterly Capital Expenditures of $570000.0 in Q1 2026, up 100.0% quarter-over-quarter from $285000.0 in Q4 2025, and up 51.19% year-over-year from $377000.0 in Q1 2025.
Mimedx's Capital Expenditures history runs 16 years deep, the most recent figure standing at $570000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 51.19% year-over-year to $570000.0; the TTM figure through Mar 2026 stood at $1.2 million (up 33.84% YoY), while the FY2025 annual figure was $1.0 million, down 38.62% from the prior year.
- Capital Expenditures came in at $570000.0 for Q1 2026 at Mimedx, up from $285000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $2.0 million in Q4 2023 to a low of -$932000.0 in Q3 2023.
- A 5-year average of $399235.3 and a median of $299000.0 in 2023 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 436.44% in 2023 and fell as far as 367.05% in 2023.
- Mimedx's Capital Expenditures stood at $667000.0 in 2022, then jumped by 197.9% to $2.0 million in 2023, then sank by 86.76% to $263000.0 in 2024, then gained by 8.37% to $285000.0 in 2025, then jumped by 100.0% to $570000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $570000.0, $285000.0, and $192000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 570,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 570,000.00 |
| Mar 31, 2026 | 570,000.00 |
| Dec 31, 2025 | 285,000.00 |
| Dec 31, 2025 | 285,000.00 |
| Sep 30, 2025 | 192,000.00 |
| Sep 30, 2025 | 192,000.00 |
| Jun 30, 2025 | 179,000.00 |
| Jun 30, 2025 | 179,000.00 |
| Mar 31, 2025 | 377,000.00 |
| Mar 31, 2025 | 377,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Sep 30, 2024 | 171,000.00 |
| Sep 30, 2024 | 171,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Sep 30, 2023 | -932,000.00 |
| Sep 30, 2023 | -932,000.00 |
| Jun 30, 2023 | 299,000.00 |
| Jun 30, 2023 | 299,000.00 |
| Mar 31, 2023 | 633,000.00 |
| Mar 31, 2023 | 633,000.00 |
| Dec 31, 2022 | 667,000.00 |
| Dec 31, 2022 | 667,000.00 |
| Sep 30, 2022 | 349,000.00 |
| Sep 30, 2022 | 349,000.00 |
| Jun 30, 2022 | 380,000.00 |
| Jun 30, 2022 | 380,000.00 |
| Mar 31, 2022 | 118,000.00 |
| Mar 31, 2022 | 118,000.00 |
| Dec 31, 2021 | 325,000.00 |
| Dec 31, 2021 | 325,000.00 |
| Sep 30, 2021 | 547,000.00 |
| Sep 30, 2021 | 547,000.00 |
| Jun 30, 2021 | 405,000.00 |
| Jun 30, 2021 | 405,000.00 |
| Mar 31, 2021 | 1.94 Mn |
| Mar 31, 2021 | 1.94 Mn |
| Dec 31, 2020 | 2.16 Mn |
| Dec 31, 2020 | 2.16 Mn |
| Sep 30, 2020 | 652,000.00 |
| Sep 30, 2020 | 652,000.00 |
| Jun 30, 2020 | 410,000.00 |
| Jun 30, 2020 | 410,000.00 |
| Mar 31, 2020 | 1.01 Mn |
| Mar 31, 2020 | 1.01 Mn |
| Dec 31, 2019 | 697,000.00 |
| Dec 31, 2019 | 697,000.00 |
| Sep 30, 2019 | 156,000.00 |
| Sep 30, 2019 | 156,000.00 |
| Jun 30, 2019 | 251,000.00 |
| Jun 30, 2019 | 251,000.00 |
| Mar 31, 2019 | 648,000.00 |
| Mar 31, 2019 | 648,000.00 |
| Dec 31, 2018 | 1.83 Mn |
| Dec 31, 2018 | 1.83 Mn |
| Sep 30, 2018 | 2.05 Mn |
| Sep 30, 2018 | 2.05 Mn |
| Jun 30, 2018 | 2.47 Mn |
| Jun 30, 2018 | 2.47 Mn |
| Mar 31, 2018 | 3.07 Mn |
| Mar 31, 2018 | 3.07 Mn |
| Dec 31, 2017 | 1.13 Mn |
| Dec 31, 2017 | 1.13 Mn |
| Sep 30, 2017 | 3.98 Mn |
| Sep 30, 2017 | 3.98 Mn |
| Jun 30, 2017 | 5,000.00 |
| Jun 30, 2017 | 5,000.00 |
| Mar 31, 2017 | 10,000.00 |
| Mar 31, 2017 | 10,000.00 |
| Dec 31, 2016 | -5.20 Mn |
| Dec 31, 2016 | -5.20 Mn |
| Sep 30, 2016 | 1.55 Mn |
| Sep 30, 2016 | 1.55 Mn |
| Jun 30, 2016 | 1.75 Mn |
| Jun 30, 2016 | 1.75 Mn |
| Mar 31, 2016 | 2.01 Mn |
| Mar 31, 2016 | 2.01 Mn |
| Dec 31, 2015 | 1.65 Mn |
| Dec 31, 2015 | 1.65 Mn |
| Sep 30, 2015 | 1.66 Mn |
| Sep 30, 2015 | 1.66 Mn |
| Jun 30, 2015 | 1.17 Mn |
| Jun 30, 2015 | 1.17 Mn |
| Mar 31, 2015 | 1.35 Mn |
| Mar 31, 2015 | 1.35 Mn |
| Dec 31, 2014 | 2.47 Mn |
| Dec 31, 2014 | 2.47 Mn |
| Sep 30, 2014 | 27,000.00 |
| Sep 30, 2014 | 27,000.00 |
| Jun 30, 2014 | 29,000.00 |
| Jun 30, 2014 | 29,000.00 |
| Mar 31, 2014 | 33,000.00 |
| Mar 31, 2014 | 33,000.00 |
| Dec 31, 2013 | -1.95 Mn |
| Dec 31, 2013 | -1.95 Mn |
| Sep 30, 2013 | 955,477.00 |
| Sep 30, 2013 | 955,477.00 |
| Jun 30, 2013 | 979,396.00 |
| Jun 30, 2013 | 979,396.00 |
| Mar 31, 2013 | 73,534.00 |
| Mar 31, 2013 | 73,534.00 |
| Dec 31, 2012 | 235,136.00 |
| Dec 31, 2012 | 235,136.00 |
| Sep 30, 2012 | 163,366.00 |
| Sep 30, 2012 | 163,366.00 |
| Jun 30, 2012 | 238,498.00 |
| Jun 30, 2012 | 238,498.00 |
| Dec 31, 2011 | 486,091.00 |
| Dec 31, 2011 | 486,091.00 |
| Sep 30, 2011 | -143,427.00 |
| Sep 30, 2011 | -143,427.00 |
| Jun 30, 2011 | 31,500.00 |
| Jun 30, 2011 | 31,500.00 |
| Mar 31, 2011 | 111,927.00 |
| Mar 31, 2011 | 111,927.00 |